The development of new chemical entities against the major diseases caused by parasites is highly desired. A library of thirty diamines analogs following a minimalist approach and supported by chemoinformatics tools have been prepared and evaluated against apicomplexan parasites. Different member of the series of N,N´-disubstituted aliphatic diamines shown in vitro activities at submicromolar concentrations and high levels of selectivity against Toxoplasma gondii and in chloroquine-sensitive and resistant-strains of Plasmodium falciparum. In order to demonstrate the importance of the secondary amines, ten N,N,N',N'-tetrasubstituted aliphatic diamines derivatives were synthesized being considerably less active than their disubstituted counterpart. Theoretical studies were performed to establish the electronic factors that govern the activity of the compounds.
Introduction
The phylum Apicomplexa includes intracellular protozoan pathogens responsible for many diseases with huge global significance in the medical and veterinary field. Plasmodium spp is an apicomplexa parasitic alveolate and is the cause of malaria in different parts of the world. Malaria afflicts millions of individuals in the tropical zones, causing serious morbidity and mortality. Toxoplasma gondii is the etiological agent of toxoplasmosis. This opportunistic pathogen has worldwide distribution, may cause cerebral pathology in immunocompromised individuals, and can produce several congenital anomalies including induction of miscarriage and neurological disorders. 1,2 T. gondii is one of the leading causes of focal central nervous system (CNS) disease in AIDS patients. Other apicomplexan organisms such as Cryptosporidium parvum and Cyclospora spp. also cause opportunistic infections in humans and have relevance in developing countries by causing diarrhoea outbreaks. 3, 4 Other members of this phylum including Theileria, Sarcocystis and Babesia spp. are important pathogens of animals. The limited arsenal of drugs available against these organisms is insufficient due to the rapid emergence of resistance, as is the case for Plasmodium or incomplete activity, as the case for chronic Toxoplasmosis. Thus, there is a continuous need develop new chemotherapies in order to combat these diseases in a unique mode of action. 5, 6 Significant efforts have been undertaken in the last decades to eradicate malaria. 7 Between 2000 and 2015 there was a registered reduction in malaria total estimated cases of more than 14% in 43 out of the 99 countries with transmission. Due to the development of resistance, antimalarial drugs which have been used to date since the advent of chloroquine, have lost effectiveness around the World. 8 Currently, artemisinin-based combination therapy (ACT) is the mainstay of malaria treatment.
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Therefore, having in mind all the successful examples via phenotypic screening, and looking to a wide spectrum candidate, we decided to assay our collection not only against P. falciparum strains but also against T. gondii. Also, cytotoxicity was evaluated in two different cell lines, African green monkey kidney epithelial (VERO) cells and human fibroblasts.
Antiplasmodium activity
All the analogs were assayed against the chloroquine sensitive Sierra Leona clone (D6) and the chloroquine resistant, Indochina clone (W2) strains of P. falciparum. To our satisfaction, most of the compounds were active against both the strains. (Table 1) . Ninety percent of the collection has an IC 50 below 5 µM, with 73% of the library being more potent than MDL-27695. In general, there are no substantial variations in the potency between the sensitive and resistant strain, suggesting that the mechanism that confer chloroquine resistance to the W2 strain does not affect sensitivity to this family of compounds.
[TABLE 1]
When comparing activities based on the benzyl substituent some clear tendencies emerge. First, there is a narrow difference between the more and the less potent member of each series, which ranges from 7.61 for R=4-BnO to 1.02 for R=3-MeO,4-BnO (Figure 2 ).
[FIGURE 2]
These slight differences in antiplasmodium efficacy of the analogs indicate that the diamine chain length does not have a strong effect the activity. At the same time, comparing the activity by the same diamine linker it seems that it does not considerably affect the potency.
The analysis of the unsubstituted benzyl derivatives (1 to 6) reveal that compounds with large chains (compounds 4, 5 and 6) are very potent (below 1 µM against both strains). A comparison with our template compound MDL-27695 reveal that these analogs are 3 to 8 times more active being shorter in length and having only two nitrogen atoms. The R=4-MeO series exhibited a similar activity profile, M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT but in this case, compound 11 with a C10 diamine was the most active with IC 50 of 0.60 µM. A different activity profile was noticed in case of 4-benzyloxy analogs (13 to 18) . The tendency changes, with 15 was the most active (n=8, IC 50 =0.39 for D6 and 0.29 µM for W2) and 18 was the least active (n=12, IC 50 =8.00 µM for both D6 and W2 strains).
Isovanillin analogues 19, 20 and 21 did not show activity up to the maximum concentration tested (8.00 µM). That anomaly could be related to the presence of a 3-OH group, which by substantially increasing hydrophilicity would alter membrane permeability. Compound 27 was the most active analog of the whole library with an IC 50 of 260 nM against the P. falciparum D6 strain and SI >31.7, only 3-fold less active than chloroquine and artemisinin and 12-fold more active than MDL-27695.
However, compound 4 showed an IC 50 of 370 nM but presents an even higher SI (>39.7).
As for the resistant strain analogue 5, which is 1.5-fold more active than chloroquine, combines the best activity and selectivity, with an IC 50 280 nM. Finally, the 3-methoxy-4-benzyloxy benzyl analogs are the most active series, with an average of 0.62 µM, with compound 27 (n=6, IC 50 =0.26 µM) the most active and 30 the less active (n=12, IC 50 =1.28 µM). Interestingly, there is slight difference activity among the compounds in this series, suggesting that increasing the chain has minimal effect on activity.
Having completed the analysis of the chain length and the aromatic ring substitution influence on the antiplamodial activity, it was important to establish the impact of the nitrogen substitution. There are many literature reports of monosubstituted diamines, but surprisingly, no precedents of bioactive tetrasubstituted aliphatic diamine analogs as antiparasitic agents. 24 With that idea in mind, ten tetrasubstituted analogs were prepared. Only the simplest aromatic substituents (R=H and 4-OMe) and five diamines (n=3,4,6,8 and 10) were selected, looking to comply with Lipinsky's rules (MW<500 Da and logP<5), additionally dodecylamine analogs were not considered because they were, on average, less active. In this opportunity, a different methodology for the synthesis was required. A one-pot procedure was selected, where two consecutive reductive aminations occurred using sodium triacetoxy borohydride, acetic acid in DCM art room temperature. 25, 26 Ten new products were prepared (Scheme 2) with 22% global yield (Table 1) . The main drawback of the reaction was the aldehyde reduction that forced using at least 4.5 equivalents of that component. Unfortunately, when more equivalents were used, the amount of the benzyl alcohol increased, impeding a clean separation of the product by column chromatography.
The new analogs were evaluated against the D6 and W2 strains of P. falciparum and did not show activity at the maximum concentration tested (8 µM) . A more detailed analysis revealed that the most active member of each series of the disubstituted analogs were at least 40 times (Compound 4, R=H, IC 50 P.f. D6 = 0.37 µM) and 19 times (compound 11, R=4-MeO, IC 50 P.f. D6 = 0.60 µM) more active than the tetrasubstituted analogs 34 and 40 (both P.f. D6 > 8.0 µM), respectively.
The antimalarial activity of N,N-disubstituted putrescine and trimethylenediamine had been previously reported. 27 Comparing the activity of the reported N,N-disubstituted with the corresponding N,N´-disubstituted analogs has shown that the last ones were always more active (between 1.5 to 7 times more potent). These results clearly demonstrate that the secondary amine is an important structural feature required for the antimalarial activity, being the N,N´-disubstitution the pattern that provided the best results.
Anti-Toxoplasma gondii activity.
To test activity of our library of diamines against T. gondii we cultured parasites on human foreskin fibroblasts in the presence of drug at 1µM or of DMSO as solvent control for 5 days, at which time point cells were fixed and stained to monitor parasite growth. The results, presented in Table 1 , show that in general the molecules in our library are not as effective in inhibiting T. gondii growth as they are with P. falciparum. Compounds 5, 12, 13, 17 and 25 (20 % of the collection) were the most effective against T. gondii and exhibited at least 75% of inhibition compared with the untreated parasites. Interestingly, compound 5 was also the most active member of the benzyl series against P. falciparum (IC 50 =0.48µM). Compound 12 is the most active on T. gondii of the 4-methoxy benzyl series, and is just two carbons larger than the analog of that family with best antiplasmodial activity.
The 4-benzyloxy benzyl containing compounds 13 and 17, which have 3 and 10 carbon chain respectively, show 75 % of T. gondii growth inhibition. Compound 15, which did not affect T. gondii growth was the member of that series (4-benzyloxy benzyl) with the best antiplasmodial. The 3methoxy-4hydroxy benzyl and the 3-methoxy 4-benzyloxy benzyl series contains a second oxygen on M A N U S C R I P T
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the benzyl ring. For the isovanillin analogues, short chains derivatives (20, 21) were the most active, behaving differently on P. falciparum were the longer analogs were the most potent.
Finally, the IC 50 of most active analogs was determined, revealing that compounds 13 and 25 has an IC 50 = 2.97 µM and 25, the most active member of the series has an IC 50 = 1.53 µM. Interestingly, none of these compounds displayed cytotoxicity on fibroblast at 10 µM, providing an SI as anti-T. gondii of 3.37 and 6.54 for 13 and 25, respectively. In summary, the overall library behavior was different between the two parasite species, showing that tachyzoites were not affected in the same way that Plasmodium erythrocytic stage (trophozoites) suggesting a different action mechanism in both parasites.
Cytotoxicity.
Vero cells are an excellent model for test cytotoxicity in vitro because is an aneuploid and a continuous cell linage. The library was tested for their effect on Vero cells to a maximum concentration of 8 µM. Only five compounds, (9, 13, 14, 25 and 28), which corresponds to 16 % of our library, were cytotoxic with a range of IC 50 between 4 to 8 µM. These five diamines analogues have a short carbon chain length, and all, with the exemption of compound 9, have benzyloxy substituents on position 4 of the aromatic ring. Nonetheless, these five compounds, particularly 25 and 28 exhibit excellent activities against apicomplexa parasites. Therefore, even being cytotoxic at low micromolar they are 10-fold higher as antimalarial providing good SI (15.9 and 14.6, respectively).
Cheminformatics and clusters analysis.
The rationale used to design this targeted library of symmetrical N,N'-disubstituted diamines allowed only two entries for scaffold modifications providing a collection that has low chemical diversity. However, using the ChemMineTools online platform, 28 it was possible to cluster the collection based on their structural matrixes. This information was useful to establish a structuralactivity relationship correlating the activity and topological parameters. (Figure 3) . The outcome of this calculation revealed the precedence of three main clusters (marked in green, red and blue in Figure 3 ) and ten secondary clusters (labelled from A to J in Table 1 ).
The main cluster (green) contains the most active analogs in both parasites. This cluster has two sets On the other hand, the most relevant parameters (molecular weight, polar surface area, volume, logBB and logP) of the collection allow us to predict the potential of the compounds as leaders, possible administration routes and to enrich SAR. To that purpose the Molinspiration 30 and ChemAxon 31 platforms were used to calculate these physicochemical parameters including the predominant molecular form at physiological pH ( Table 2) . (Figure 5 ). However, we could constrain the logP range values between 2.66 to 3.75 for the highest values of activity against T. gondii.
However, our library contains ionizable groups that are charged at physiological pH, which make logD a better descriptor of the lipophilicity of these molecules. The calculated logD at physiological pH (7.4) of the collection is presented in Table 2 , with 90 % of the collection being ≤ 5 (-1.09 to 5.92).
Given the chemical nature of the amine groups in the designed structures, the lipophilicity decreases markedly as the pH drops. This fact would suggest that the molecule could have a better interaction in the acidic environment of some organelles, in the same way as ethambutol does within lysosomes and autophagosomes. 32 In summary, this analysis reveals that most of the compounds has good potential to be orally active drug candidates.
The distribution of the compounds between blood and brain is a very important consideration for new candidate drug molecules. In case T. gondii, which effectively infects neurons and causes disease in the brain, good drug candidates must be able to cross the blood brain barrier (BBB). To predict that properly we calculated the logBB using COSMOquick. 33 This calculation shows that 75% of our compounds have logBB > 0.3. It has been shown that molecules with logBB > 0.3 cross the BBB readily while molecules with logBB < −1 are poorly distributed to the brain, 34, 35 thus our library includes numerous compounds that would be expected to enter the brain. 
Analysis of the molecular electrostatic potential of the aromatic portion.
Molecular electrostatic potentials (MEPs) were used for analyzing drug-receptor and enzymesubstrate interaction and other recognition processes, based on the assumption that those potentials described how different molecular regions will interact with other approaching chemical species.
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In order to determine how the electronic potential of the aromatic portion of the analogs affects the activity, a tridimensional molecular electrostatic potential map of the aromatic portion of the prepared N,N´-dibenzyl aliphatic diamines derivatives were performed at the van der Waals contact surface. To simplify the calculations, only substituted N-methyl benzyl were used (Figure 6a . R=H; R=4-OMe; R=4-OBn; R=3-OH,4-OMe; R=3-MeO,4-BnO). The geometries of the groups were optimized using B3LYP functional along with 6-311++G(d,p). (Figure 6b ) The electrostatic potentials, superimposed onto a surface of constant electron charge density were calculated (0.001 e/au 3 , Figure 6c ).
It is well known that electrostatic potential has been defined as the energy of interaction of a positively charge point with the nuclei and the electrons of a molecule. On Figure 6C the coloring area represents the electrostatic potential, V(r), providing a measurement of the molecular charge distribution. The calculated MEP maps for the five analogs that go from -0.1408 au in deepest red for the strongest attraction, to +0.1152 au in deepest blue for the strongest repulsion. Negative regions V(r) are usually associated with a lone pair of electronegative atoms and the π electrons of the unsaturated hydrocarbons. In this case, the MEPs are different for each of the five analogs studied and, as expected, is affected by the aromatic ring subtituents. The negative potentials are localized at the oxygens of the phenols and methoxy groups. On the other side, the positive potential is localized on the nitrogen amine and is significantly affected by the substituent on the aromatic ring.
When the activity of each series was correlated with the electrotactic potential, two clear tendencies emerged. On one side, the activity of the analogs with benzyloxy group seems governed by steric effects. On the other side, the activity of the series is clearly associated to the negative electrostatic potential, being detrimental to the antiplasmodial activity.
[FIGURE 6]

Conclusions
Enzymes are usually arranged into symmetrical homodimers or tetramers, with the consequent active site organization in a highly symmetrical fashion. Thus, symmetrical inhibitors or biological actuators will correspond generally to their binding site. 36 Numerous examples of symmetrical active compounds have been reported including anticancer, 37, 38 antiparasitic, 39,40 antitubercular 41 and enzyme 42, 43 between others. The compounds designed and prepared on this work were inspired on the symmetrical compound MDL-27695. We were looking to simplify that compound´s structure, removing nitrogens from the carbon chain and inquiring the effect of oxygenated substituents of the aromatic ring on the activity. Therefore, we searched for a fast and easy way to explore the chemical space of the proposed disubstituted N,N´-aliphatic diamines. A major advantage of the proposed scaffold lies in the fact that the synthesis of symmetrical derivatives is extremely straightforward and only required commercially available starting materials. The synthesis did not need additional protection/deprotection steps, minimizing the synthesis to a single-step, being a clear example of atom economy and green chemistry. 44, 45 It has been suggested that symmetry and planarity disruption is a valuable strategy to improve aqueous solubility. 46 The synthesized compounds are very flexible preventing a good packing that facilitates the dissolution process. Also, the two nitrogen atoms on the aliphatic chain provide the required polarity to improve the water solubility and bioavailability. Therefore, from the solubility point of view, the symmetrical scaffold prepared did not represent a disadvantage.
The one-pot synthetic procedure provided 30 symmetric derivatives in good yields. In vitro studies have demonstrated that most of the analogs (26 of 30 compounds) are active against P. falciparum at micromolar level or below (9 compounds at submicromolar level). On the other hand, the related parasite T. gondii does not seem as sensitive to these type of compounds (6 of 30 compounds shows at least 75% of activity at 1 µM). The differences on the sensitivity between T. gondii and P. falciparum could be attributed to a favoured incorporation to the red bloods cells or the interaction with different molecular targets due to their metabolic divergences.
A series of tetrasubstituted N,N´-aliphatic diamines were prepared being considerable less active against both P. falciparum strains than the bis-substituted counterpart demonstrating the importance of the secondary amine on the activity.
A summary of the structure-activity analysis is detailed on Figure 7 . As can be seen, the antimalarial activity of the compounds is fairly responsive to the structural variations in most of the series, with certain substituents increasing activity, like R=H, or R=3-MeO,4-BnO. MEPs results clearly shown that the aromatic subtituents affect the electrostatic potential of the nitrogen and the aromatic ring and that, together with the steric factors, can be correlated with the activity. Chain length M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT appears to slightly influence potency, being the electronic and the steric the most critical factors modulating the activity.
The selection of the best drug candidate as antimalarial and anti-T. gondii should combine a low IC 50 values with Lipinski´s rules compliance, low cytotoxicity (high SI) and ideal range of logBB (only for T. gondii). Following that premise, analogs 4, 5, 15, 26 and 27 are the most promising antimalarial candidates, having submicromolar IC 50 and SI>20. Filtering out the selection by the ADME parameters points to compound 4 as the best candidate. In the case of T. gondii, analogs 13 and 25 based on the activity are the most promising, but of these only 13 is predicted to cross the BBB, which would make it the best candidate for future studies (Figure 5) . It is likely that the mechanism of action of these compounds differs between these two parasites. Additionally, the targets and mechanisms of action in each parasite might be different across the different series. Future studies with the best candidates will focus on elucidating mode of action. The fact that similar compounds act by different mechanisms in trypanosomatids 22, 47 and the pathogenic fungus Pneumocystis carinii 48 support this hypothesis. Polyamine oxidase have been studied as a possible target of MDL-27695 on P.
falciparum. 49 The oxidation of that compound by purified rat liver oxidase release benzaldehyde and the N-monosubstituted analog, then goes to another oxidation cycle releasing the free polyamine. Also, polyamine concentration increases inside P. falciparum infected red blood cells by newly recruited transporters.
Similar degradation products have been studied on Plasmodium falciparum, 50 displaying similar potency to the bis-benzyl disubstituted analogs but holding a bulky antracene ring. Having in mind that monosubstituted diamines have been described as polyamine transport inhibitors, 51-53 a possible action mechanism could involve oxidation to activate the compound that then inhibit the polyamine transport.
In conclusion, the structural simplification of MDL-27695 provided potent antimalarial analogs validating our initial hypothesis. The fact that compounds 4 and 5, which has strong similarities to MDL-27695 but only have 2 nitrogens, supports the idea that the bis-N-benzyl moiety could be acting as the pharmacophore within those structures. Lastly, the N,N´-disubstituted aliphatic diamine analogs provides unique tools to develop new antiparasitic agents and to study biological processes related to polyamines metabolism. A possible multitarget action mechanism should be validated by non-directed metabolomics and proteomics study. 
In vitro activity against T. gondii.
Toxoplasma parasites (RH strain parasites expressing the green fluorescent protein, GFP) were maintained in human foreskin fibroblast (HFF) monolayers in Dulbecco's medium supplemented with 10% heat-inactivated fetal bovine serum (FBS), 100 U/ml penicillin, and 100 g/ml streptomycin.
Uninfected and infected HFFs cells were maintained in a humidified incubator at 37 °C with 5% CO 2 .
For primary screen, 10 3 parasites were allowed to infect a confluent HFF monolayer. At 8 hours postinfection, the medium was replaced with medium containing 1 or 10 µM of each compound. Three days later cultures were monitored by fluorescence microscopy to monitor parasite growth. To determine IC 50 HFFs were infected with 80 parasites and after four hours extracellular parasites were washed off and media with drug at a range of concentrations was added. At 5 days post-infection, cultures were fixed with methanol for 2 minutes and stained with crystal violet to visualized plaques which were enumerated. Percentage survival was calculated by dividing the number of plaques in drug over that in equivalent amount of DMSO. Experiments were performed in three experimental and biological replicates.
Cytotoxicity assay on Vero cells.
The in vitro cytotoxicity was determined against mammalian kidney fibroblasts (VERO). The assay was performed in 96-well tissue culture-treated plates as described earlier. Briefly, cells were seeded to the wells of the plate (25,000 cells/well) and incubated for 24 h. Samples were added and plates were again incubated for 48 h. The number of viable cells was counted and the plot for EC 50 performed.
ADME/toxicity predictions.
Computational modeling to estimate the bioavailability, aqueous solubility, blood brain barrier potential, human intestinal absorption, mutagenicity, and toxicity for the compounds was performed using the ChemMineTools and Osiris Property.
General procedure for N,N-diamines disubstituted synthesis
Aldehyde (3 eq dissolved in the same mixture of solvents) was added to a solution of diamine (1 eq) in an anhydrous mixture of DCM:methanol (3:1). The mixture was refluxed overnight, the solvent was evaporated and the crude di-imine was dissolved in an anhydrous mixture of DCM:methanol (1:1).
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The solution was cooled at 0 o C, and sodium borohydride (3 eq) was added portion wise. The reaction was allowed to warm to room temperature and stirred for additional 12 hours. Excess of sodium borohydride was quenched acidifying with 10% HCl, with subsequent addition of ammonium hydroxide to reach a basic pH. Phases were separated and the aqueous phase extracted with DCM (3 x 20 mL). Combined organic extracts were dried with sodium sulphate and evaporated. Products were purified by flash chromatography. of N1,N3-dibenzylpropane-1,3-diamine (1) . 
Synthesis
Synthesis of N1,N3-bis(4-methoxybenzyl)propane-1,3-diamine (7).
Following the general reaction conditions for the disubstituted diamines synthesis, the reaction was 
Synthesis of N1,N4-bis(4-methoxybenzyl)butane-1,4-diamine (8).
Following the general reaction conditions for the disubstituted diamines synthesis, the reaction was worked up and purified to afford 115 mg of white solid (isolated yield: 77 %). 1 
Synthesis of N1,N6-bis(4-methoxybenzyl)hexane-1,6-diamine (9).
Following the general reaction conditions for the disubstituted diamines synthesis, the reaction was worked up and purified to afford 37 mg of white solid (isolated yield: 30 %). 1 
Synthesis of N1,N8-bis(4-methoxybenzyl)octane-1,8-diamine (10).
Following the general reaction conditions for the disubstituted diamines synthesis, the reaction was worked up and purified to afford 95 mg of white solid (isolated yield: 59 %). 1 2.59 (t, 4H, J= 6.9 Hz, N-CH 2 ); 1.48 (m, 4H, C2-H and C7-H); 1.28 (m, 8H, C3-H to C6-H). 13 
Synthesis of N1,N10-bis(4-methoxybenzyl)decane-1,10-diamine (11).
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Synthesis of N1,N12-bis(4-methoxybenzyl)dodecane-1,12-diamine (12).
Synthesis of N1,N3-bis(4-(benzyloxy)benzyl)propane-1,3-diamine (13).
Following the general reaction conditions for the disubstituted diamines synthesis, the reaction was 6.15. Synthesis of N1,N6-bis(4-(benzyloxy)benzyl)hexane-1,6-diamine (15) . 6.18. Synthesis of N1,N12-bis(4-(benzyloxy)benzyl)dodecane-1,12-diamine (18) . 
Synthesis of N1,N4-bis(4-(benzyloxy)benzyl)butane-1,4-diamine (14).
Synthesis of N1,N8-bis(4-(benzyloxy)benzyl)octane-1,8-diamine (16).
Synthesis of N1,N10-bis(4-(benzyloxy)benzyl)decane-1,10-diamine (17).
Synthesis of 5,5'-((propane-1,3-diylbis(azanediyl)) bis(methylene))bis(2methoxyphenol) (19).
Following the general reaction conditions for the disubstituted diamines synthesis, the reaction was worked up and purified to afford 180 mg of white solid (isolated yield: 96 %). 1 H NMR (CDCl 3 ) δ 6.79 (m, 6H, aromatics); 3.87(s, 6H, O-CH 3 ); 3.69 (s, 4H, Ar-CH 2 ); 2.73 (t, 4H, J=6.6 Hz, N-CH 2 ); 1.74 (m, 2H, C2-H). 13 5'-((hexane-1,6-diylbis(azanediyl) ) bis(methylene))bis(2-methoxyphenol) (21) . 5'-((dodecane-1,12-diylbis(azanediyl) ) bis(methylene))bis(2methoxyphenol) (24). 
Synthesis of N1,N3-bis(4-(benzyloxy)-3-methoxybenzyl)propane-1,3-diamine (25).
Synthesis of N1,N4-bis(4-(benzyloxy)-3-methoxybenzyl)butane-1,4-diamine (26).
Synthesis of N1,N6-bis(4-(benzyloxy)-3-methoxybenzyl)hexane-1,6-diamine (27).
Following the general reaction conditions for the disubstituted diamines synthesis, the reaction was worked up and purified to afford 159 mg of white solid (isolated yield: 81 %). 1 
Synthesis of N1,N8-bis(4-(benzyloxy)-3-methoxybenzyl)octane-1,8-diamine (28).
Synthesis of N1,N12-bis(4-(benzyloxy)-3-methoxybenzyl) dodecane-1,12-diamine (30).
Following the general reaction conditions for the disubstituted diamines synthesis, the reaction was worked up and purified to afford 135 mg of white solid (isolated yield: 90 %). 1 
General procedure for N,N,N',N'-diamines tetrasubstituted synthesis
To a solution of aldehyde (4.5 eq.) and diamine (1 eq) in anhydrous DCM, NaBH(AcO) 3 (7.2 eq.) and acetic acid (6.4 eq.) were added at room temperature. The reaction was stirred under inert atmosphere for 24 hours and then was quenched with a 10% NaHCO 3 
Computational methods
The geometries of the products were optimized using B3LYP functional [54] [55] [56] • Theoretical studies were carried out to show the electronic differences between the synthesized compounds. A possible multitarget action mechanism have been proposed.
